Home »
An Ebola outbreak now occurring in Guinea was almost certainly started by someone who survived West Africa’s historic 2014-16 epidemic, harbored the virus for at least five years and then transmitted it via semen to a sex partner, researchers reported on Friday. The finding, based on genetic sequencing of virus samples taken from patients in the current outbreak, shocked researchers. […]
Read more
Fox News Flash Headlines February 14 Guinea, the West Africa country, announced Sunday that the Ebola virus has become an epidemic after the deaths of three people and hospitalizations of four others, a report said. Reuters reported that the country’s health system is not faced with the daunting task of responding to outbreaks of COVID-19 and Ebola. The report pointed […]
Read more
Ebola virus is one of the world’s deadliest pathogens, and scientists now report new details of how the virus alters the host immune response for its own benefit during infection. In a study published today in Cell, the researchers identified antiviral defense genes that the virus suppresses, and other genes the virus activates to potentially boost its replication in cells. […]
Read more
BREAKING NEWS: FDA may approve emergency use authorization of Ebola drug remdesivir TODAY after Dr Fauci called early results of one study ‘very optimistic’ The FDA may announce its decision allowing emergency use authorization of an antiviral remdesivir for coronavirus patients as early as Wednesday It comes as Gilead Sciences treated 397 severely ill patients and found more than half of […]
Read more
BENI, Congo — A new case of the Ebola virus has been confirmed in eastern Congo, just three days before the country expected to declare an end to the outbreak, the World Health Organization said Friday. The new case was confirmed in Beni, a community that had been an epicenter of the second-deadliest Ebola outbreak in history. It had been […]
Read more
(HealthDay)—The first Ebola vaccine approved by the U.S. Food and Drug Administration is a single-dose injection called Ervebo. The vaccine from Merck & Co. is approved to protect against the Zaire ebolavirus in people ages 18 years and older. In the United States, Ebola infections are rare. Confirmed cases have involved people in other countries who became infected and then […]
Read more
There has been a rapid increase in the global measles outbreak, with reported cases jumping 300 percent in the first three months of 2019 compared with the same period last year, according to the World Health Organization. As reasons for the increase, the organization has cited a deep mistrust of vaccines, gaps in immunization coverage and lack of access to […]
Read more
The worst part of sampling a dead gorilla for Ebola, said Dr. William B. Karesh, is the flies. “You can imagine the sense of panic,” he said. “A hundred thousand ants and carrion flies are coming off the carcass or climbing up your arms. They get inside your hood and are crawling on your face or biting you. “After half […]
Read more
Two experimental treatments to treat Ebola infection work so well that they will now be offered to all patients in the Democratic Republic of Congo, scientists announced Monday. The antibody-based treatments are so powerful — “Now we can say that 90 percent can come out of treatment cured,” one scientist said — that they raise hopes that the disastrous epidemic […]
Read more
Researchers in Uganda are launching the largest-ever trial of an experimental Ebola vaccine that is expected to be deployed in neighboring Congo, where a deadly outbreak has killed over 1,800 people. The trial of the Janssen Pharmaceuticals vaccine involves up to 800 people and is supported by Doctors without Borders and the London School of Hygiene and Tropical Medicine. Pontiano […]
Read more